UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UbiQ Bio BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11225
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polypeptides. It products are used in accelerate drug discovery, target identification and validation, hit-to-lead discovery, lead on target validation and optimization, and other applications. The company’s technology platform consists of UbiQ-Block, UbiQ-Click, and UbiQ-Syn that are used to develop products and services in the ubiquitin field. UbiQ is headquartered in Amsterdam, the Netherlands.

UbiQ Bio BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV – Key Competitors 14
UbiQ Bio BV – Key Employees 15
UbiQ Bio BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
UbiQ Bio BV, Pharmaceuticals & Healthcare, Key Facts 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Deals By Therapy Area, 2012 to YTD 2018 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV, Key Competitors 14
UbiQ Bio BV, Key Employees 15
UbiQ Bio BV, Joint Venture 16

List of Figures
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cavitation Technologies Inc (CVAT):企業の財務・戦略的SWOT分析
    Summary Cavitation Technologies Inc (Cavitation) is an energy service company that develops processing technologies. The company processes fluidic mixtures, liquids, emulsions and suspended solids. Its technology uses hydrodynamic cavitation that comprise fluid’s vaporization and growth, pulsation, …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SynCore Biotechnology Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that new drug by research and development management and integration of technology resources. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05; and diagn …
  • Nabors Industries Ltd.:戦略・SWOT・企業財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sky plc:企業の戦略・SWOT・財務情報
    Sky plc - Strategy, SWOT and Corporate Finance Report Summary Sky plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Potlatch Corporation:戦略・SWOT・企業財務分析
    Potlatch Corporation - Strategy, SWOT and Corporate Finance Report Summary Potlatch Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Puget Energy, Inc.:企業の戦略・SWOT・財務分析
    Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ascent Resources Plc (AST):石油・ガス:M&Aディール及び事業提携情報
    Summary Ascent Resources Plc. (Ascent) is an independent upstream exploration and production company. It explores for, develops and produces oil and natural gas from its project in Slovenia. It operates the Petisovci tight gas project in Slovenia. The Petisovci Tight Gas project is in proximity to t …
  • The Siam Cement Public Co Ltd:戦略・SWOT・企業財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides com …
  • Visioneering Technologies Inc:製品パイプライン分析
    Summary Visioneering Technologies Inc (VTI) is a medical device company that develops and commercializes on-eye and in-eye solutions for presbyopia, astigmatism and myopia progression control. The company offers technology consists of myopia correction technology, silicone hydrogel material platform …
  • Solco Biomedical Co Ltd (043100):医療機器:M&Aディール及び事業提携情報
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. Its surgical instruments comprise forceps, scissors, needle …
  • Crystal Rock Holdings, Inc:企業の戦略・SWOT・財務情報
    Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report Summary Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • HDFC Bank Ltd:戦略・SWOT・企業財務分析
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Sutures India Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Sutures India Private Limited (SIPL) is a medical device company that manufactures and markets surgical sutures. The company provides absorbable sutures, surgical tape, surgical mesh, bone wax, nonabsorbable sutures, skin stapler and surgical gloves. Its absorbable sutures include plain catg …
  • Firstmark Corporation:企業の戦略・SWOT・財務情報
    Firstmark Corporation - Strategy, SWOT and Corporate Finance Report Summary Firstmark Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆